Zhongke Qingzi is a clinical diagnostic mass spectrometry reagent developer, based in the field of precision medicine, focusing on the R&D and production of clinical diagnostic mass spectrometry reagents and providing third-party medical testing services. A few days ago, Zhongke Qingzi received an angel round of investment of 5 million yuan. The investor is the direct investment fund of Guicheng technology innovation enterprises.
This article is reproduced from: https://www.itjuzi.com/investevent/13570785
This site is for inclusion only, and the copyright belongs to the original author.